A Study of BPI-460372 in Advanced Solid Tumor Patients

NCT05789602 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

82

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumor

Interventions

DRUG: BPI-460372

Sponsor

Betta Pharmaceuticals Co., Ltd.